4-[(1S)-6-Chloro-2,3-dihydro-1H-inden-1-yl]-7,8-dimethoxyquinazoline (ACI)

Isocorydine hydrochloride

(2E)-3-(3,4-Dimethoxyphenyl)-1-(2-hydroxyphenyl)-2-propen-1-one (ACI)

(+)-Licarin

1,1-Dimethoxyoctane (ACI)

Cimiracemoside D

1,2-Dihydro-5-[1-[[(3S)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]oxy]-3-isoquinolinyl]-3H-1,2,4-triazol-3-one (ACI)

5-Fluoro-4-(4-fluoro-2-methoxyphenyl)-N-[4-[[[S(R)]-S-methylsulfonimidoyl]methyl]-2-pyridinyl]-2-pyridinamine (ACI)

Cafestol (6CI, 7CI, 8CI)

3-Methyl-2′-O-methyluridine (ACI)

Rosiridin

Arnidiol

Immunoglobulin, anti-(human CD19 antigen) (human-Mus musculus monoclonal MOR00208 heavy chain), disulfide with human-Mus musculus monoclonal MOR00208 κ-chain, dimer (ACI)

Nisoxetine

Guselkumab

6-Chloro-7-[(2R)-2-[[(3-chloro-4-methoxy-2-pyridinyl)oxy]methyl]-1-pyrrolidinyl]-1-[6-[3-(dimethylamino)-1-azetidinyl]-3-pyridinyl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid (ACI)

α-[(9R)-6-Hydroxy-6-oxido-1,12-dioxo-9-[(1-oxooctadecyl)oxy]-5,7,11-trioxa-2-aza-6-phosphanonacos-1-yl]-ω-[3-[[5-[(2,5-dioxo-1-pyrrolidinyl)oxy]-1,5-dioxopentyl]amino]propoxy]poly(oxy-1,2-ethanediyl) sodium salt (1:1) (ACI)

L-Alanyl-L-valyl-L-seryl-L-α-glutamyl-L-isoleucyl-L-glutaminyl-L-phenylalanyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucylglycyl-L-lysyl-L-histidyl-L-leucyl-L-seryl-L-seryl-L-methionyl-L-α-glutamyl-L-arginyl-L-valyl-L-α-glutamyl-L-tryptophyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-valyl-L-histidyl-L-asparaginyl-L-phenylalanine (ACI)

Immunoglobulin G1, anti-(mucin MUC1) (human-Mus musculus monoclonal PankoMab-GEX heavy chain), disulfide with human-Mus musculus monoclonal PankoMab-GEX light chain, dimer (ACI)

Flanvotumab